Non-alcoholic fatty liver disease (NAFLD) is now characterized as the hepatic manifestation of metabolic syndrome, is the leading cause of liver cirrhosis and currently affects a quarter of the world's population. A number of recent studies have focused on the prevalence of neurodegeneration